Parkinson's Disease
Conditions
Keywords
auditory cueing device, Parkinson's disease, freezing, gait, mobility
Brief summary
The primary aim of the study is to evaluate the effect of an IACD i.e. Apple iPod-shuffle, on freezing and gait speed in people with a diagnosis of PD through the implementation of a randomised controlled trial. A secondary aim of the study is to evaluate the impact of such a device on the quality of life of people with stroke through the administration of a self-report questionnaire. The IACD will be pre-loaded with an individualised auditory cueing frequency (metronome sound) matched to the walking speed of the individual with PD.
Detailed description
The investigators calculated and pre-loaded 100 baseline frequencies (less 10%) in the sound of a metronome beat in an MP3 format (30 - 130 BPM) \[38\] onto a DVD-Rom. A user manual was created with a set of instructions that gives each physiotherapist a step-by-step guide on how to calculate the correct beat for their participants and how to successfully upload this beat onto the iPod. In addition physiotherapists in participating centres attended a training session on how to complete the tasks. A pack including the DVD-Rom, user manual, information leaflet and consent was sent to participating centres. Recruitment is due to commence in September 2008.
Interventions
Each participant will be given an iPod containing an auditory cue in the form of a continuous metronome beat, individualised to the patient's walking frequency (less 10%).Participants will be instructed to listen to the cueing when they are performing any mobility related tasks.
Sponsors
Study design
Eligibility
Inclusion criteria
* PD * medically stable * willing to give informed consent * freeze at least once per week (minimum score of 2 on item 3 of the FOGQ) for at least 2 seconds(minimum score of 1 on item 4 of FOGQ) * MMSE Score greater than 24
Exclusion criteria
* attending physiotherapy at time of recruitment * unwilling to give informed consent * not medically stable * cognitive impairment (MMSE score less than 24) * acure co-morbidity that prevents mobility
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Freezing of Gait Questionnaire | Day 8, Day 15, Day 23 and 3 month follow up |
Secondary
| Measure | Time frame |
|---|---|
| Timed Up and Go Test | Day 8, Day 15, Day 23 and three month follow-up |
| Modified Falls Efficacy Scale | Day 8, Day 15, Day 23 and three month follow-up |
| 10 Metre Walk Test | Day 8, Day 15, Day 23 and three month follow-up |
Countries
Ireland